DE69829174D1 - Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein) - Google Patents

Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)

Info

Publication number
DE69829174D1
DE69829174D1 DE69829174T DE69829174T DE69829174D1 DE 69829174 D1 DE69829174 D1 DE 69829174D1 DE 69829174 T DE69829174 T DE 69829174T DE 69829174 T DE69829174 T DE 69829174T DE 69829174 D1 DE69829174 D1 DE 69829174D1
Authority
DE
Germany
Prior art keywords
protein
expression
modified
sleep
virus envelope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829174T
Other languages
English (en)
Other versions
DE69829174T2 (de
Inventor
Axel Rethwilm
Dirk Lindemann
Jan Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectoria Forschungsfoerderungs Verein Ev 97 De
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of DE69829174D1 publication Critical patent/DE69829174D1/de
Publication of DE69829174T2 publication Critical patent/DE69829174T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17051—Methods of production or purification of viral material
    • C12N2740/17052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE1998629174 1997-03-13 1998-03-13 Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein) Expired - Lifetime DE69829174T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2199989 1997-03-13
CA 2199989 CA2199989A1 (en) 1997-03-13 1997-03-13 Expression of a foamy virus envelope protein
PCT/IB1998/000343 WO1998040507A1 (en) 1997-03-13 1998-03-13 Expression of a modified foamy virus envelope protein

Publications (2)

Publication Number Publication Date
DE69829174D1 true DE69829174D1 (de) 2005-04-07
DE69829174T2 DE69829174T2 (de) 2006-01-26

Family

ID=4160166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1998629174 Expired - Lifetime DE69829174T2 (de) 1997-03-13 1998-03-13 Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)

Country Status (8)

Country Link
EP (1) EP0977881B1 (de)
JP (1) JP2001514517A (de)
AT (1) ATE290093T1 (de)
AU (1) AU733948B2 (de)
CA (1) CA2199989A1 (de)
DE (1) DE69829174T2 (de)
ES (1) ES2236888T3 (de)
WO (1) WO1998040507A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309071B2 (en) 2008-06-27 2012-11-13 Vectoria Forschungsforderungs Verein E.V. Foamy viral envelope genes
KR20230065640A (ko) * 2021-11-05 2023-05-12 중앙대학교 산학협력단 2-플라스미드 시스템으로 제조된 가짜 포미 바이러스 및 이의 용도

Also Published As

Publication number Publication date
DE69829174T2 (de) 2006-01-26
ES2236888T3 (es) 2005-07-16
ATE290093T1 (de) 2005-03-15
WO1998040507A1 (en) 1998-09-17
EP0977881B1 (de) 2005-03-02
JP2001514517A (ja) 2001-09-11
AU6110698A (en) 1998-09-29
AU733948B2 (en) 2001-05-31
EP0977881A1 (de) 2000-02-09
CA2199989A1 (en) 1998-09-13

Similar Documents

Publication Publication Date Title
ATE288489T1 (de) Vp-antigene des jc-virus
DE59410380D1 (de) Endosomolytisch wirksame partikel
LU91392I2 (fr) "La particule viroïde de la protéine L1 recombinante du papillomavirus humain de type 16" - Cervarix
JP2013213034A (ja) パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法
UA42089C2 (uk) Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва
PT757717E (pt) Vacinas de papilomavirus
UA85536C2 (en) Viral antigens
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
DE69939169D1 (de) Aav5 vektoren und deren verwendung
WO1999046366A8 (en) Uses for humane non-autologous mesenchymal stem cells
ATE202487T1 (de) Mono- oder polyfunktionelle konjugate von polylysine
AU1875495A (en) 5-substituted derivatives of mycophenolic acid
DE69938201D1 (de) Mikropartikel
EP1013757A3 (de) Abgeschwächte Formen des Rinderdiarrhöevirus
DE69829174D1 (de) Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
EP1100545A4 (de) Regulierte expression von rekombinanten proteinen unter verwendung von rns-viren
WO1997004099A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
AUPM358894A0 (en) Modified papilloma virus l2 protein and vlps formed therefrom
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
EP1015560A4 (de) Veränderte, kleine rna-viren
MX9701267A (es) Receptor de glutamato.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LINDEMANN, DIRK, DR., 01257 DRESDEN, DE

Owner name: RETHWILM, AXEL, PROF., 97078 WUERZBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: VECTORIA FORSCHUNGSFOERDERUNGS VEREIN E.V., 97, DE